XSUS:CA:TSX-iShares ESG MSCI USA Index (CAD)

ETF | US Equity |

Last Closing

CAD 39.97

Change

-0.33 (-0.82)%

Market Cap

CAD 0.58B

Volume

800.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-28 )

Largest Industry Peers for US Equity

Symbol Name Price(Change) Market Cap
VFV:CA Vanguard S&P 500 Index ETF

-0.42 (-0.31%)

CAD 21.09B
ZSP:CA BMO S&P 500

-0.25 (-0.30%)

CAD 17.10B
XSP:CA iShares Core S&P 500 (CAD Hedg..

+0.02 (+0.03%)

CAD 11.46B
VUN:CA Vanguard US Total Market

-0.09 (-0.09%)

CAD 10.87B
XUS:CA iShares Core S&P 500 Index ETF

-0.12 (-0.25%)

CAD 8.70B
HXS:CA Global X S&P 500 Corporate Cla..

-0.19 (-0.24%)

CAD 4.34B
VSP:CA Vanguard S&P 500 CAD hedged

+0.18 (+0.20%)

CAD 4.04B
QUU:CA Mackenzie US Large Cap Equity ..

-0.14 (-0.06%)

CAD 3.60B
XUU:CA iShares Core S&P US Total Mark..

-0.02 (-0.04%)

CAD 3.34B
ZUE:CA BMO S&P 500 (CAD Hedged)

+0.14 (+0.18%)

CAD 3.23B

ETFs Containing XSUS:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (US Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -11.00% 7% C- 18% F
Dividend Return 0.20% 17% F 5% F
Total Return -10.80% 9% A- 18% F
Trailing 12 Months  
Capital Gain 7.91% 59% D- 62% D
Dividend Return 1.03% 26% F 18% F
Total Return 8.94% 58% F 56% F
Trailing 5 Years  
Capital Gain 80.29% 71% C- 75% C
Dividend Return 7.16% 20% F 10% F
Total Return 87.45% 64% D 69% C-
Average Annual (5 Year Horizon)  
Capital Gain 14.37% 76% C+ 80% B-
Dividend Return 15.29% 75% C 78% C+
Total Return 0.93% 36% F 36% F
Risk Return Profile  
Volatility (Standard Deviation) 15.07% 36% F 54% F
Risk Adjusted Return 101.46% 61% D- 93% A
Market Capitalization 0.58B 53% F 62% D

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.